# Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor

> **NCT03299452** · PHASE2 · UNKNOWN · sponsor: **Haining Health-Coming Biotech Co., Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Metastatic Cancer

## Interventions

- **DRUG:** Non Chemotherapy
- **DRUG:** Chemotherapy and target therapy
- **DRUG:** Chinese herb medicine

## Key facts

- **NCT ID:** NCT03299452
- **Lead sponsor:** Haining Health-Coming Biotech Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03299452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03299452, "Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03299452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*